Royal Bank of Canada
TBIO

Royal Bank of Canada’s Translate Bio, Inc. Common Stock TBIO Stock Holding History

Royal Bank of Canada’s Portfolio TBIO Stock Details TBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-30,316
Closed -$834K – 8135
2021
Q2 		$834K Buy
30,316
+3,557
+13% +$69.9K ﹤0.01% 3820
2021
Q1 		$441K Buy
26,759
+7,992
+43% +$182K ﹤0.01% 4296
2020
Q4 		$346K Buy
18,767
+7,767
+71% +$139K ﹤0.01% 4434
2020
Q3 		$150K Sell
11,000
-884
-7% -$13.6K ﹤0.01% 4731
2020
Q2 		$213K Buy
11,884
+1,112
+10% +$16.8K ﹤0.01% 4422
2020
Q1 		$108K Buy
10,772
+8,702
+420% +$71.3K ﹤0.01% 4733
2019
Q4 		$17K Buy
2,070
+1,470
+245% +$13.6K ﹤0.01% 5939
2019
Q3 		$6K Buy
+600
New +$5.67K ﹤0.01% 5992
2019
Q2 		– Sell
-15,000
Closed -$153K – 7343
2019
Q1 		$153K Hold
15,000
– – ﹤0.01% 4514
2018
Q4 		$113K Buy
15,000
+4,561
+44% +$33.4K ﹤0.01% 4663
2018
Q3 		$104K Buy
+10,439
New +$122K ﹤0.01% 4844

Royal Bank of Canada's TBIO Position: Q3 2021 in Review

Royal Bank of Canada sold out of Translate Bio, Inc. Common Stock (TBIO) in Q3 2021, closing a stake of 30,316 shares — an estimated $834K sold.

Royal Bank of Canada first reported a position in TBIO in Q3 2018 and held it in 11 quarters. The position peaked at $834K in Q2 2021. 0 funds tracked by Wall St. Rank hold TBIO as of Q3 2021.

  • Royal Bank of Canada reported no remaining Translate Bio, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Royal Bank of Canada sold 30,316 Translate Bio, Inc. Common Stock shares in Q3 2021, an estimated $834K.
  • Royal Bank of Canada first reported a position in Translate Bio, Inc. Common Stock in Q3 2018 and held it in 11 quarters.
  • Royal Bank of Canada's Translate Bio, Inc. Common Stock position peaked at $834K in Q2 2021.
  • 0 funds tracked by Wall St. Rank held Translate Bio, Inc. Common Stock as of Q3 2021.

Based on Royal Bank of Canada's 13F filing for Q3 2021, filed 15 Nov 2021.